A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study

[1]  P. Cassoni,et al.  A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups , 2021, Frontiers in Oncology.

[2]  G. Langs,et al.  Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma , 2021, Cancers.

[3]  Chengcheng Guo,et al.  Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma , 2020, Frontiers in Pharmacology.

[4]  T. Shimoyama,et al.  Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B‐cell lymphoma , 2020, Hematological oncology.

[5]  A. Kuan,et al.  A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma , 2020, Cancer medicine.

[6]  Yun Liang,et al.  Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases , 2019, Annals of Hematology.

[7]  A. Desai,et al.  Prognostic value of hypoalbuminemia at diagnosis in de novo non-M3 acute myeloid leukemia , 2019, Leukemia & lymphoma.

[8]  U. Schlegel,et al.  Have treatment protocols for primary CNS lymphoma advanced in the past 10 years? , 2019, Expert review of anticancer therapy.

[9]  K. Hoang-Xuan,et al.  Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas. , 2019, The oncologist.

[10]  B. Liu,et al.  The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphoma. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[11]  Seok-Hyun Kim,et al.  Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP. , 2018, Leukemia research.

[12]  R. Feng,et al.  Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP , 2016, International Journal of Hematology.

[13]  D. Torpy,et al.  Corticosteroid-Binding Globulin: A Review of Basic and Clinical Advances , 2016, Hormone and Metabolic Research.

[14]  Wen-Qi Jiang,et al.  Distributed under Creative Commons Cc-by 4.0 the Pretreatment Albumin to Globulin Ratio Predicts Survival in Patients with Natural Killer/t-cell Lymphoma , 2022 .

[15]  R. Greil,et al.  The significance of pretreatment anemia in the era of R‐IPI and NCCN‐IPI prognostic risk assessment tools: a dual‐center study in diffuse large B‐cell lymphoma patients , 2015, European journal of haematology.

[16]  M. Sekeres,et al.  Albumin as a prognostic marker in myelodysplastic syndromes: still relevant after all these years , 2015, Leukemia & lymphoma.

[17]  E. Phillips,et al.  Primary CNS Lymphoma , 2014, Current Hematologic Malignancy Reports.

[18]  J. Chavez,et al.  Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era , 2014, Annals of Hematology.

[19]  Seonwoo Kim,et al.  Effect of Nutritional Status on Survival Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP , 2014, Nutrition and cancer.

[20]  Seth R Flaxman,et al.  A systematic analysis of global anemia burden from 1990 to 2010. , 2014, Blood.

[21]  Wen-Qi Jiang,et al.  Primary mediastinal large B-cell lymphoma (PMLBCL) in Chinese patients: clinical characteristics and prognostic factors , 2011, International journal of hematology.

[22]  M. Inoue,et al.  Plasma testosterone and sex hormone‐binding globulin concentrations and the risk of prostate cancer among Japanese men: A nested case‐control study , 2010, Cancer science.

[23]  Y. Oki,et al.  Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy , 2009, Leukemia & lymphoma.

[24]  R. Hoover,et al.  Serum concentrations of estrogens, sex hormone‐binding globulin, and androgens and risk of breast cancer in postmenopausal women , 2006, International journal of cancer.

[25]  E. Iannitto,et al.  Splenic marginal zone lymphoma: a prognostic model for clinical use. , 2006, Blood.

[26]  J. Spivak.  The anaemia of cancer: death by a thousand cuts , 2005, Nature Reviews Cancer.

[27]  G. Kaysen,et al.  POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and Nutrition , 2004, Seminars in dialysis.

[28]  S. Wade,et al.  Prevalence and outcomes of anemia in cancer: a systematic review of the literature. , 2004, The American journal of medicine.

[29]  M. Dimopoulos,et al.  Treatment of Relapsed/Refractory Multiple Myeloma with Thalidomide-based Regimens: Identification of Prognostic Factors , 2004, Leukemia & lymphoma.

[30]  Eric R. Ziegel,et al.  The Elements of Statistical Learning , 2003, Technometrics.

[31]  M. Tisdale.  Cachexia in cancer patients , 2002, Nature Reviews Cancer.

[32]  D. McMillan,et al.  Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. , 1998, The Journal of nutrition.

[33]  R. D'angio.  Is There a Role for Albumin Administration in Nutrition Support? , 1994, The Annals of pharmacotherapy.

[34]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[35]  C. McClain,et al.  Tumor necrosis factor-mediated hypoalbuminemia in rabbits. , 1988, The Journal of nutrition.

[36]  Junmin Li,et al.  The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China , 2014, Annals of Hematology.

[37]  K. Hoang-Xuan,et al.  A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. , 2006, Blood.

[38]  P. Goggin,et al.  Cancer cachexia. , 2005, QJM : monthly journal of the Association of Physicians.